Growth hormone delivery devices: current features and potential for enhanced treatment adherence-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Growth hormone delivery devices: current features and potential for enhanced treatment adherence

Published:2016-11-04 Issue:11 Volume:14 Page:1253-1264
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Rohrer Tilman R.¹,Horikawa Reiko²,Kappelgaard Anne-Marie³

Affiliation:

1. Department of Pediatrics and Adolescent Medicine, Saarland University Medical Center, Homburg/Saar, Germany

2. Division of Endocrinology and Metabolism, National Center for Child Health and Development, Tokyo, Japan

3. Clinical, Medical and Regulatory, Novo Nordisk International Operations A/G, Zurich, Switzerland

Funder

Novo Nordisk A/S

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2017.1243526

Reference92 articles.

1. Current Indications for Growth Hormone Therapy for Children and Adolescents

2. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation

3. Continuation of Growth Hormone (GH) Replacement in GH-Deficient Patients during Transition from Childhood to Adulthood: A Two-Year Placebo-Controlled Study

4. Effects of Growth Hormone Administration on Inflammatory and Other Cardiovascular Risk Markers in Men with Growth Hormone Deficiency

5. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards more tolerable subcutaneous administration: Review of contributing factors for improving combination product design;Advanced Drug Delivery Reviews;2024-06

2. Pharmaceutical and biotech industry perspectives on optimizing patient experience and treatment adherence through subcutaneous drug delivery design;Advanced Drug Delivery Reviews;2024-06

3. Key Device Attributes for Injectable Somatostatin Receptor Ligand Therapy in Acromegaly and Neuroendocrine Tumours;Advances in Therapy;2023-08-12

4. Integration of nurse-led virtual reviews with growth hormone device-linked patient adherence information: a mixed methods feasibility study;Frontiers in Endocrinology;2023-05-31

5. Identifying Patients for Self-Administration of Omalizumab;Advances in Therapy;2022-09-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3